Loading clinical trials...
Loading clinical trials...
Does a New Add on (or Adjunctive) Therapy Used in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.
To investigate the efficacy of needle bleb revisions with mitomycin C with subconjunctival bevacizumab in promoting both filtering success and favorable bleb morphologic features.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Wills Eye Institute, Glaucoma Service
Philadelphia, Pennsylvania, United States
Start Date
February 1, 2009
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
July 9, 2018
63
ACTUAL participants
bevacizumab
DRUG
balanced salt solution
OTHER
Lead Sponsor
Wills Eye
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07396441